A Phase I, Open Label, Single Sequence,Drug Interaction Study Evaluating Plasma GSK1349572 and Tenofovir Pharmacokinetics in Healthy Adult Subjects (ING111604).
Phase of Trial: Phase I
Latest Information Update: 09 Oct 2009
At a glance
- Drugs Dolutegravir; Tenofovir disoproxil fumarate
- Indications Hepatitis B; HIV infections
- Focus Pharmacokinetics
- 27 Oct 2008 Trial end date changed from 1 Sep 2008 to 1 Oct 2008 as reported by ClinicalTrials.gov.
- 27 Oct 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Sep 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.